{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T19:59:18Z","timestamp":1771790358776,"version":"3.50.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Merck & Co"},{"name":"Merck & Co"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.mayocp.2020.06.004","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T08:02:51Z","timestamp":1596268971000},"page":"1780-1795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Routine Childhood Vaccines Given From 1 through 18 Years of Age"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6355-8752","authenticated-orcid":false,"given":"Robert M.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mayocp.2020.06.004_bib1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.mayocp.2019.06.007","article-title":"Routine childhood vaccines given in the first 11 months of life","volume":"95","author":"Jacobson","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.mayocp.2020.06.004_bib2","first-page":"241","article-title":"Ten great public health achievements\u2014United States, 1900\u20131999","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"29","key":"10.1016\/j.mayocp.2020.06.004_bib3","first-page":"621","article-title":"Achievements in public health, 1900\u20131999: control of infectious diseases","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"19","key":"10.1016\/j.mayocp.2020.06.004_bib4","first-page":"619","article-title":"Ten great public health achievements\u2014United States, 2001\u20132010","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.mayocp.2020.06.004_bib5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.15585\/mmwr.mm6805a4","article-title":"Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger \u2014 United States, 2019","volume":"68","author":"Robinson","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mayocp.2020.06.004_bib8","series-title":"Epidemiology and Prevention of Vaccine-Preventable Diseases","year":"2015"},{"key":"10.1016\/j.mayocp.2020.06.004_bib9","series-title":"Epidemiology and Prevention of Vaccine-Preventable Diseases","year":"2017"},{"issue":"40","key":"10.1016\/j.mayocp.2020.06.004_bib11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.15585\/mmwr.mm6840e2","article-title":"National update on measles cases and outbreaks \u2014 United States, January 1\u2013October 1, 2019","volume":"68","author":"Patel","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mayocp.2020.06.004_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-065X.2010.00925.x","article-title":"Measles virus-induced suppression of immune responses","volume":"236","author":"Griffin","year":"2010","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.mayocp.2020.06.004_bib13","first-page":"1","article-title":"Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"McLean","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.mayocp.2020.06.004_bib14","series-title":"M-M-R II (Measles, Mumps, And Rubella Virus Vaccine Live) [package insert]","year":"2019"},{"key":"10.1016\/j.mayocp.2020.06.004_bib15","series-title":"ProQuad Measles, Mumps, Rubella and Varicella Virus Vaccine Live [package insert]","year":"2019"},{"issue":"RR8","key":"10.1016\/j.mayocp.2020.06.004_bib16","first-page":"1","article-title":"Measles, mumps, and rubella \u2014 vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"47","author":"Watson","year":"1998","journal-title":"MMWR Recomm Rep"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2020.06.004_bib17","first-page":"S116","article-title":"Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age","volume":"189","author":"Redd","year":"2004","journal-title":"J\u00a0Infect Dis"},{"issue":"40","key":"10.1016\/j.mayocp.2020.06.004_bib18","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.15585\/mmwr.mm6740a4","article-title":"Vaccination coverage among children aged 19\u201335 months \u2014 United States, 2017","volume":"67","author":"Hill","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"41","key":"10.1016\/j.mayocp.2020.06.004_bib19","doi-asserted-by":"crossref","first-page":"905","DOI":"10.15585\/mmwr.mm6841e1","article-title":"Vaccination coverage with selected vaccines and exemption rates among children in kindergarten \u2014 United States, 2018\u201319 School Year","volume":"68","author":"Seither","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10111","key":"10.1016\/j.mayocp.2020.06.004_bib21","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/S0140-6736(17)31463-0","article-title":"Measles","volume":"390","author":"Moss","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.mayocp.2020.06.004_bib22","doi-asserted-by":"crossref","first-page":"ofx146","DOI":"10.1093\/ofid\/ofx146","article-title":"Vaccine rejection and hesitancy: a review and call to action","volume":"4","author":"Smith","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"10.1016\/j.mayocp.2020.06.004_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/M18-2101","article-title":"Measles, mumps, rubella vaccination and autism: a nationwide cohort study","volume":"170","author":"Hviid","year":"2019","journal-title":"Ann Intern Med"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2020.06.004_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0749-3797(99)00118-X","article-title":"Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services","volume":"18","author":"Briss","year":"2000","journal-title":"Am J Prev Med"},{"issue":"4","key":"10.1016\/j.mayocp.2020.06.004_bib25","doi-asserted-by":"crossref","first-page":"E835","DOI":"10.1542\/peds.2013-2365","article-title":"Effective messages in vaccine promotion: a randomized trial","volume":"133","author":"Nyhan","year":"2014","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.mayocp.2020.06.004_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.vaccine.2014.11.017","article-title":"Does correcting myths about the flu vaccine work? An experimental evaluation of the effects of corrective information","volume":"33","author":"Nyhan","year":"2015","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.mayocp.2020.06.004_bib27","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.mayocp.2015.09.006","article-title":"Vaccine hesitancy","volume":"90","author":"Jacobson","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.mayocp.2020.06.004_bib28","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.oooo.2019.06.012","article-title":"Viral Mumps: Increasing occurrences in the vaccinated population","volume":"128","author":"Lau","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"1","key":"10.1016\/j.mayocp.2020.06.004_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.15585\/mmwr.mm6701a7","article-title":"Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak","volume":"67","author":"Marin","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"34","key":"10.1016\/j.mayocp.2020.06.004_bib30","doi-asserted-by":"crossref","first-page":"749","DOI":"10.15585\/mmwr.mm6834a4","article-title":"Mumps in detention facilities that house detained migrants \u2014 United States, September 2018\u2013August 2019","volume":"68","author":"Leung","year":"2019","journal-title":"Mmwr-Morbid Mortal W"},{"issue":"3","key":"10.1016\/j.mayocp.2020.06.004_bib31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ajic.2018.09.003","article-title":"Mumps outbreak with high complication rates among residents in a university teaching hospital","volume":"47","author":"Perez-Alba","year":"2019","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.mayocp.2020.06.004_bib32","series-title":"Vaccines","author":"Plotkin","year":"2013"},{"issue":"40","key":"10.1016\/j.mayocp.2020.06.004_bib33","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.15585\/mmwr.mm6740a7","article-title":"Notes from the field: rubella infection in an unvaccinated pregnant woman \u2014 Johnson County, Kansas, December 2017","volume":"67","author":"Wallin","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"45","key":"10.1016\/j.mayocp.2020.06.004_bib34","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.15585\/mmwr.mm6645a4","article-title":"Progress in rubella and congenital rubella syndrome control and elimination \u2014 worldwide, 2000\u20132016","volume":"66","author":"Grant","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"21","key":"10.1016\/j.mayocp.2020.06.004_bib35","doi-asserted-by":"crossref","first-page":"20485","DOI":"10.2807\/ese.18.21.20485-en","article-title":"Ongoing outbreak of rubella among young male adults in poland: increased risk of congenital rubella infections","volume":"18","author":"Paradowska-Stankiewicz","year":"2013","journal-title":"Euro Surveill"},{"issue":"23","key":"10.1016\/j.mayocp.2020.06.004_bib36","first-page":"457","article-title":"Nationwide Rubella Epidemic\u2014Japan, 2013","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mayocp.2020.06.004_bib37","series-title":"VARIVAX [package insert]","year":"2019"},{"issue":"RR-4","key":"10.1016\/j.mayocp.2020.06.004_bib38","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"10.1016\/j.mayocp.2020.06.004_bib39","doi-asserted-by":"crossref","first-page":"e20182917","DOI":"10.1542\/peds.2018-2917","article-title":"Incidence of herpes zoster among children: 2003\u20132014","volume":"144","author":"Weinmann","year":"2019","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.mayocp.2020.06.004_bib40","doi-asserted-by":"crossref","first-page":"e20183561","DOI":"10.1542\/peds.2018-3561","article-title":"Varicella vaccine: what have you done for me lately?","volume":"144","author":"Gershon","year":"2019","journal-title":"Pediatrics"},{"issue":"46","key":"10.1016\/j.mayocp.2020.06.004_bib41","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.1016\/j.vaccine.2018.09.013","article-title":"Herpes zoster in the context of varicella vaccination \u2013 An equation with several variables","volume":"36","author":"Wutzler","year":"2018","journal-title":"Vaccine"},{"issue":"RR-7","key":"10.1016\/j.mayocp.2020.06.004_bib42","first-page":"1","article-title":"Prevention of hpatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Fiore","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.mayocp.2020.06.004_bib43","series-title":"VAQTA (Hepatitis A Vaccine, Inactivated) [package insert]","year":"2018"},{"key":"10.1016\/j.mayocp.2020.06.004_bib44","series-title":"HAVRIX (Hepatitis A Vaccine) [package insert]","year":"2018"},{"issue":"43","key":"10.1016\/j.mayocp.2020.06.004_bib45","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.15585\/mmwr.mm6743a5","article-title":"Update: recommendations of the Advisory Committee on Immunization Practices for use of hepatitis A vaccine for postexposure prophylaxis and for preexposure prophylaxis for international travel","volume":"67","author":"Nelson","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.mayocp.2020.06.004_bib46","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jval.2015.02.004","article-title":"Public health impact and cost-effectiveness of hepatitis A vaccination in the United States: a disease transmission dynamic modeling approach","volume":"18","author":"Dhankhar","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.mayocp.2020.06.004_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.15585\/mmwr.su6501a6","article-title":"Progress toward eliminating hepatitis A disease in the United States","volume":"65","author":"Murphy","year":"2016","journal-title":"MMWR Suppl"},{"issue":"6","key":"10.1016\/j.mayocp.2020.06.004_bib49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.15585\/mmwr.mm6806a6","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of hepatitis A vaccine for persons experiencing homelessness","volume":"68","author":"Doshani","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.mayocp.2020.06.004_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6905a1","article-title":"Prevention of hepatitis A virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices, 2020","volume":"69","author":"Nelson","year":"2020","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.mayocp.2020.06.004_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6803a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2019\u201320 influenza season","volume":"68","author":"Grohskopf","year":"2019","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.mayocp.2020.06.004_bib52","doi-asserted-by":"crossref","first-page":"e20153280","DOI":"10.1542\/peds.2015-3280","article-title":"Complete influenza vaccination trends for children six to twenty-three months","volume":"137","author":"Santibanez","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.mayocp.2020.06.004_bib53","series-title":"FLUMIST QUADRIVALENT [package insert]","year":"2019"},{"issue":"7","key":"10.1016\/j.mayocp.2020.06.004_bib54","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.mayocp.2020.06.004_bib55","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.anai.2017.01.030","article-title":"Live attenuated influenza vaccine use and safety in children and adults with asthma","volume":"118","author":"Duffy","year":"2017","journal-title":"Ann Allerg Asthma Immunol"},{"issue":"1","key":"10.1016\/j.mayocp.2020.06.004_bib56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.anai.2017.10.020","article-title":"Administration of influenza vaccines to egg allergic recipients: a practice parameter update 2017","volume":"120","author":"Greenhawt","year":"2018","journal-title":"Ann Allerg Asthma Immunol"},{"issue":"4","key":"10.1016\/j.mayocp.2020.06.004_bib57","doi-asserted-by":"crossref","first-page":"e20192478","DOI":"10.1542\/peds.2019-2478","article-title":"Recommendations for prevention and control of influenza in children, 2019\u20132020","volume":"144","year":"2019","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.mayocp.2020.06.004_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6505a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2016\u201317 influenza season","volume":"65","author":"Grohskopf","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.1016\/j.mayocp.2020.06.004_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6602a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2017\u201318 influenza season","volume":"66","author":"Grohskopf","year":"2017","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.mayocp.2020.06.004_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6703a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2018\u201319 influenza season","volume":"67","author":"Grohskopf","year":"2018","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"10.1016\/j.mayocp.2020.06.004_bib61","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.vaccine.2019.11.055","article-title":"A\u00a0study to evaluate the immunogenicity and shedding of live attenuated influenza vaccine strains in children 24-<48 months of age","volume":"38","author":"Mallory","year":"2020","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.mayocp.2020.06.004_bib62","doi-asserted-by":"crossref","first-page":"643","DOI":"10.15585\/mmwr.mm6722a5","article-title":"Update: ACIP recommendations for the use of quadrivalent live attenuated influenza vaccine (LAIV4) \u2014 United States, 2018\u201319 influenza season","volume":"67","author":"Grohskopf","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.mayocp.2020.06.004_bib65","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/524875","article-title":"Risk of female human papillomavirus acquisition associated with first male sex partner","volume":"197","author":"Winer","year":"2008","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2020.06.004_bib67","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/cts.12166","article-title":"Human papillomavirus vaccination: a case study in translational science","volume":"7","author":"Palmer","year":"2014","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.mayocp.2020.06.004_bib68","series-title":"GARDASIL 9 [package insert]","year":"2018"},{"issue":"11","key":"10.1016\/j.mayocp.2020.06.004_bib69","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"49","key":"10.1016\/j.mayocp.2020.06.004_bib70","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.15585\/mmwr.mm6549a5","article-title":"Use of a 2-dose schedule for human papillomavirus vaccination \u2014 updated recommendations of the Advisory Committee on Immunization Practices","volume":"65","author":"Meites","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"32","key":"10.1016\/j.mayocp.2020.06.004_bib71","doi-asserted-by":"crossref","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Meites","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"33","key":"10.1016\/j.mayocp.2020.06.004_bib72","first-page":"718","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years \u2014 United States, 2018","volume":"68","author":"Walker","year":"2019","journal-title":"MMWR Recomm Rep"},{"issue":"RR-2","key":"10.1016\/j.mayocp.2020.06.004_bib73","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"issue":"20","key":"10.1016\/j.mayocp.2020.06.004_bib74","first-page":"630","article-title":"FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"50","key":"10.1016\/j.mayocp.2020.06.004_bib75","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males\u00a0\u2014 Advisory Committee on Immunization Practices (ACIP), 2011","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.mayocp.2020.06.004_bib76","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1370\/afm.1188","article-title":"Adolescent primary care visit patterns","volume":"8","author":"Nordin","year":"2010","journal-title":"Ann Fam Med"},{"issue":"3","key":"10.1016\/j.mayocp.2020.06.004_bib77","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MOP.0000000000000353","article-title":"Update on barriers to human papillomavirus vaccination and effective strategies to promote vaccine acceptance","volume":"28","author":"Bratic","year":"2016","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"10.1016\/j.mayocp.2020.06.004_bib78","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.vaccine.2016.11.012","article-title":"Clinician knowledge, clinician barriers, and perceived parental barriers regarding human papillomavirus vaccination: association with initiation and completion rates","volume":"35","author":"Rutten","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.mayocp.2020.06.004_bib79","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1542\/peds.2012-2384","article-title":"Reasons for not vaccinating adolescents: national immunization survey of teens, 2008\u20132010","volume":"131","author":"Darden","year":"2013","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.mayocp.2020.06.004_bib80","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1158\/1055-9965.EPI-15-1159","article-title":"Parents' support for school-entry requirements for human papillomavirus vaccination: a national study","volume":"25","author":"Calo","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.mayocp.2020.06.004_bib81","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1080\/21645515.2016.1150394","article-title":"Impact of school-entry and education mandates by states on HPV vaccination coverage: analysis of the 2009-2013 National Immunization Survey\u2013Teen","volume":"12","author":"Perkins","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.mayocp.2020.06.004_bib82","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jamapediatrics.2018.4283","article-title":"Requiring human papillomavirus vaccination for school entry","volume":"173","author":"Bayefsky","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.mayocp.2020.06.004_bib83","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1001\/jamapediatrics.2018.3327","article-title":"Human papillomavirus vaccination and school entry requirements: politically challenging, but not impossible","volume":"173","author":"Daley","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"2","key":"10.1016\/j.mayocp.2020.06.004_bib84","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1586\/14760584.2016.1116947","article-title":"The most effective and promising population health strategies to advance human papillomavirus vaccination","volume":"15","author":"Jacobson","year":"2016","journal-title":"Expert Rev Vaccines"},{"issue":"RR-2","key":"10.1016\/j.mayocp.2020.06.004_bib85","first-page":"1","article-title":"Prevention and control of meningococcal disease recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Cohn","year":"2013","journal-title":"Mmwr Recomm Rep"},{"key":"10.1016\/j.mayocp.2020.06.004_bib86","series-title":"Menactra [package insert]","year":"2019"},{"key":"10.1016\/j.mayocp.2020.06.004_bib87","series-title":"Menveo [package insert]","year":"2019"},{"key":"10.1016\/j.mayocp.2020.06.004_bib89","series-title":"TRUMENBA [package insert]","year":"2019"},{"key":"10.1016\/j.mayocp.2020.06.004_bib90","series-title":"BEXSERO [package insert]","year":"2019"},{"issue":"22","key":"10.1016\/j.mayocp.2020.06.004_bib91","first-page":"608","article-title":"Use of serogroup B meningococcal vaccines in persons aged \u2265 10 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015","volume":"64","author":"Folaranmi","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"41","key":"10.1016\/j.mayocp.2020.06.004_bib92","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.15585\/mmwr.mm6441a3","article-title":"Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the Advisory Committee on Immunization Practices, 2015","volume":"64","author":"MacNeil","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"19","key":"10.1016\/j.mayocp.2020.06.004_bib93","doi-asserted-by":"crossref","first-page":"509","DOI":"10.15585\/mmwr.mm6619a6","article-title":"Updated recommendations for use of MenB-FHbp serogroup B meningococcal vaccine \u2014 Advisory Committee on Immunization Practices, 2016","volume":"66","author":"Patton","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.mayocp.2020.06.004_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6702a1","article-title":"Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"67","author":"Liang","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.mayocp.2020.06.004_bib95","author":"Ezeanolue"},{"issue":"18","key":"10.1016\/j.mayocp.2020.06.004_bib96","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1503\/cmaj.092048","article-title":"Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline","volume":"182","author":"Taddio","year":"2010","journal-title":"CMAJ"},{"issue":"4","key":"10.1016\/j.mayocp.2020.06.004_bib97","first-page":"49","article-title":"The C.A.S.E. approach: guidance for talking to vaccine-hesitant parents","volume":"96","author":"Jacobson","year":"2013","journal-title":"Minn Med"},{"issue":"2","key":"10.1016\/j.mayocp.2020.06.004_bib98","first-page":"38","article-title":"Making the C.A.S.E. for the human papillomavirus vaccine: how to talk to parents and adolescents","volume":"97","author":"Jacobson","year":"2014","journal-title":"Minn Med"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620306017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620306017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:33:35Z","timestamp":1758418415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619620306017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":89,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0025619620306017"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.06.004","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Routine Childhood Vaccines Given From 1 through 18 Years of Age","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}